25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1

By Amir Eitan   Cecchini Reena   Ganz Patricia   Costantino Joseph   Beddows Samantha   Hood Nicola   Goodwin Pamela  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1077-1088

Springer Publishing Company

Access to resources Recommend Favorite

MUC1 expression in primary breast cancer: the effect of tamoxifen treatment

By Hanson J.M.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 3, 2001-06 ,pp. : 215-222

Springer Publishing Company

Access to resources Recommend Favorite

Cathepsin D and Breast Cancer

By Westley B.R.   May F.E.B.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 15-24

Elsevier

Access to resources Recommend Favorite

Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients

By            

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1467-1474

Spandidos Publications

Access to resources Recommend Favorite

Survival and prognosticators of gastric cancer that recurs after adjuvant chemotherapy with S-1

By Aoyama Toru  

Gastric Cancer, Vol. 14, Iss. 2, 2011-06 ,pp. : 150-154

Springer Publishing Company

Access to resources Recommend Favorite